Company Filing History:
Years Active: 2010-2012
Title: The Innovations of Rosalinda Syto
Introduction
Rosalinda Syto is an accomplished inventor based in Nutley, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides related to human protein kinase B gamma (AKT3). With a total of 2 patents, her work has implications for cancer research and therapeutic development.
Latest Patents
Her latest patents include the invention of a kinase domain polypeptide of human protein kinase B gamma (AKT3). This invention provides, in part, AKT3 polypeptides and methods of use, along with nucleic acids encoding these polypeptides. Additionally, she has developed polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3), which also includes methods for screening for AKT3 inhibitors.
Career Highlights
Rosalinda Syto is currently employed at Schering Corporation, where she continues to advance her research in biotechnology. Her work has been pivotal in understanding the mechanisms of AKT3 and its potential as a target for therapeutic intervention.
Collaborations
She has collaborated with notable colleagues, including Andrew Joseph Prongay and Thierry Olivier Fischmann, to further her research and innovations in the field.
Conclusion
Rosalinda Syto's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in cancer treatment and research.